Cannabis company Vireo Growth's Q4 revenue surges on M&A deals

Vireo Growth

17/03/2026 11:13

Overview

U.S. cannabis operator's Q4 revenue rose 318% yr/yr, driven by recent M&A deals

Company announced pending acquisitions of Eaze, Schwazze, PharmaCann assets, and MOU for Hawthorne

Q4 adjusted EBITDA grew 347% yr/yr as company realized synergies from recent integrations

Outlook

Vireo Growth expects pending acquisitions to close in first half of 2026

Result Drivers

M&A ACTIVITY - Q4 revenue surge attributed to recently closed mergers and acquisitions expanding retail and wholesale footprint

SAME STORE SALES - Pro forma same store sales increased 22% yr/yr

SYNERGIES FROM INTEGRATION - Company realized corporate overhead synergies following integration of Deep Roots, Proper, and Wholesome acquisitions

Company press release: ID:nGNX6FxxQw

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
$104.50 mln
Q4 Gross Profit
$56.90 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)